FENC

Price-

Market Cap344.04 M

Float33.75 M

Country-

Sector-

Exchange-

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

FENC

Sector

-

Industry

-

Country

-

Exchange

Vol Avg.

N/A

Inst Own

41.800%

Float & OS

33.75 M / 35.07 M

Cash/Shr

$1.2

Market Cap & Ev

Short Interest

1.4%

Borrow Rate

1.2774%

Days to Cover

3.78

Overall Offering Risk

Warrant Exercise Risk

Research Report

Customize research

Recent Articles (8)

Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026

Globe Newswire

Nov 6, 2026, 5:50 AM

Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026

Globe Newswire

Sep 17, 2026, 7:30 AM

Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Globe Newswire

Aug 11, 2026, 7:01 AM

Fennec Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 11, 2026

Globe Newswire

Aug 5, 2026, 7:01 AM

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Globe Newswire

Jun 15, 2026, 6:00 AM

Fennec Announces Results of Annual Meeting

Globe Newswire

Jun 10, 2026, 4:30 PM

Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting

Globe Newswire

May 21, 2026, 6:01 PM

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Globe Newswire

May 18, 2026, 4:30 PM

Recent Filings

Type	Title	Date Released

Earnings